GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Klaria Pharma Holding AB (publ) KLAR.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

0.51

-2.29%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 9.0m

FY2016FY2025

Net income

−SEK 38.9m

FY2016FY2025

Free cash flow

−SEK 70.1m

FY2016FY2025

Shareholders' equity

−SEK 3.9m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 9.0mSEK 2.2mSEK 8.5mSEK 5.9mSEK 6.1mSEK 7.2mSEK 4.2mSEK 649,000SEK 2.3m—
Research and developmentSEK 20.1mSEK 22.1mSEK 24.9mSEK 51.4mSEK 63.5mSEK 41.2mSEK 16.9mSEK 22.3mSEK 9.5mSEK 10.0m
Operating income−SEK 33.4m−SEK 31.2m−SEK 31.8m−SEK 55.8m−SEK 50.4m−SEK 48.8m−SEK 21.1m−SEK 27.3m−SEK 21.8m−SEK 14.6m
Net income−SEK 38.9m−SEK 47.8m−SEK 35.8m−SEK 63.8m−SEK 53.5m−SEK 51.4m−SEK 22.5m−SEK 27.3m−SEK 21.6m−SEK 14.6m
Diluted earnings per share-0.21-0.33-0.34-1.07-0.97-1.08-0.73-0.89-0.70-0.49

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 40.8mSEK 57.3mSEK 72.9mSEK 120.3mSEK 118.3mSEK 132.4mSEK 101.7mSEK 106.3mSEK 155.9mSEK 162.0m
Cash and short-term investmentsSEK 342,000SEK 598,000SEK 1.2mSEK 16.8mSEK 25.5mSEK 31.3mSEK 2.9mSEK 8.0mSEK 17.1mSEK 31.1m
Total liabilitiesSEK 44.6mSEK 54.0mSEK 31.8mSEK 44.2mSEK 48.9mSEK 22.8mSEK 19.6mSEK 11.6mSEK 2.3mSEK 2.0m
DebtSEK 9.7mSEK 23.1mSEK 18.9mSEK 17.1mSEK 31.7mSEK 10.3mSEK 10.8m———
Shareholders' equity−SEK 3.9mSEK 3.3mSEK 41.1mSEK 76.1mSEK 69.4mSEK 109.6mSEK 82.1mSEK 94.7mSEK 153.5mSEK 160.0m
Shares outstanding185m144m107m60m55m48m31m31m31m30m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−SEK 35.0m−SEK 11.9m−SEK 9.1m−SEK 49.7m−SEK 24.8m−SEK 35.3m−SEK 14.8m−SEK 9.1m−SEK 12.1m−SEK 14.4m
Capital spending−SEK 35.0m——−SEK 42,000−SEK 42,000−SEK 33,000−SEK 33,000−SEK 33,000−SEK 65,000−SEK 65,000
Free cash flow−SEK 70.1m−SEK 11.9m−SEK 9.1m−SEK 49.8m−SEK 24.8m−SEK 35.3m−SEK 14.8m−SEK 9.2m−SEK 12.1m−SEK 14.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueSEK 10,000SEK 101,000−SEK 27,000SEK 42,000—SEK 9.0mSEK 1.1mSEK 1.1m
Operating income−SEK 10.8m−SEK 7.2m−SEK 7.1m−SEK 6.6m−SEK 14.6mSEK 3.0m−SEK 11.0m−SEK 2.8m
Net income−SEK 12.9m−SEK 8.7m−SEK 8.5m−SEK 8.7m−SEK 20.1m−SEK 1.6m−SEK 15.6m−SEK 7.9m
Diluted earnings per share-0.05-0.04-0.05-0.05-0.11-0.01-0.11-0.05
Cash from operations−SEK 14.0m—−SEK 2.0m−SEK 30.0m−SEK 2.0m—SEK 1.0m−SEK 3.0m
Capital spending——−SEK 35.0m—————
Free cash flow——−SEK 37.0m—————
Total assetsSEK 37.5mSEK 30.0mSEK 40.8mSEK 47.4mSEK 50.3mSEK 54.9mSEK 57.3mSEK 64.4m
Cash and short-term investmentsSEK 8.5mSEK 260,000SEK 342,000SEK 2.5mSEK 2.0mSEK 1.5mSEK 598,000SEK 537,000
Debt——SEK 9.7mSEK 617,000—SEK 617,000SEK 23.1m—
Shareholders' equity−SEK 33.6m−SEK 20.6m−SEK 3.9mSEK 4.5m−SEK 18.4mSEK 1.7mSEK 3.3mSEK 12.9m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue15.3%4.5%—
Operating income-15.7%-7.3%19.6%
Net income-15.2%-5.4%21.4%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-574.3%-595.5%-646.5%—
Net margin-770.4%-728.2%-748.5%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-3.2-0.6-0.5-0.4-1.4-1.2-1.3-2.3-3.0-3.8
Price to sales13.713.12.34.612.18.86.997.728.2—

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.